<?xml version='1.0'?>
<!DOCTYPE art SYSTEM 'http://www.biomedcentral.com/xml/article.dtd'>
<art>
   <ui>AGAH-3-P0003</ui>
   <ji>AGAH</ji>
   <fm>
      <dochead>Poster presentation</dochead>
      <bibl>
         <title>
            <p>Assessment of renal function from values of serum cystatin C concentration</p>
         </title>
         <aug>
            <au id="A1" pa="yes">
               <snm>&#352;r&#225;mek</snm>
               <fnm>P</fnm>
               <insr iid="I1"/>
               <email>psramek@pharmacon.cz</email>
            </au>
            <au id="A2">
               <snm>&#352;kopek</snm>
               <mnm/>
               <fnm>J</fnm>
               <insr iid="I1"/>
            </au>
            <au id="A3">
               <snm>Reh </snm>
               <mnm/>
               <fnm>C</fnm>
               <insr iid="I2"/>
            </au>
         </aug>
         <insg>
            <ins id="I1">
               <p> Nemocnice Strahov Praha, Praha, Czech Republic</p>
            </ins>
            <ins id="I2">
               <p> Pharmacon Research, Berlin, Germany</p>
            </ins>
         </insg>
         <source>AGAH</source>
         <series>
            <title>
               <p>2004 Annual Meeting of the Arbeitsgemeinschaft f&#252;r Angewandte Humanpharmakologie (Association for Applied Human Pharmacology)</p>
            </title>
         </series>
         <pubdate>2004</pubdate>
         <volume>3</volume>
         <fpage>p0003</fpage>
         <note>Berlin, Germany, 29 February -2 March 2004</note>
      </bibl>
      <history>
         <rec>
            <date>
               <day>18</day>
               <month>5</month>
               <year>2004</year>
            </date>
         </rec>
         <pub>
            <date>
               <day>28</day>
               <month>5</month>
               <year>2004</year>
            </date>
         </pub>
      </history>
   </fm>
   <bdy>
      <sec>
         <st>
            <p/>
         </st>
         <p>The aim of this study was to prove that serum cystatin C is a reliable marker of renal function and that it is a surrogate of creatinine in the estimation of the clearance capabilities of kidney. Knowledge of the creatinine clearance (CrCl) is important for the assessment of glomerular filtration rate (GFR), which is basis for dose adaptation during the treatment, for optimal dose selection in chemotherapy, for the control of renal graft function after transplantation, during clinical trials, etc. Most of the methods for assessment of GFR have its limitations and they bring a burden for a patient.</p>
         <p>Serum cystatin C, a cysteine protease inhibitor,<sup/>has been suggested as a new marker of glomerular filtration<sup/>rate (GFR). This study explored the possibility of replacing<sup/>the creatinine clearance (CrCl) as surrogate of GFR with cystatin<sup/>C in early detection of renal impairment.<sup/></p>
      </sec>
      <sec>
         <st>
            <p>Methods</p>
         </st>
         <p>
				Serum creatinine and cystatin C concentrations as well<sup/>as 24-h CrCl were determined simultaneously in 37 subjects. Among<sup/>them, 18 were healthy and 19 with different stage of renal disease.<sup/>Creatinine was determined using a Jaff&#233;<sup/>method. Serum cystatin C was determined by a particle-enhanced<sup/>turbidimetric immunoassay.<sup/></p>
      </sec>
      <sec>
         <st>
            <p>Results</p>
         </st>
         <p>
				Cystatin C and creatinine correlated significantly when we compared all subjects (r = 0.77), the same correletion was between  cystatin C and CrCl  (<it>r</it> = -0.78). Close correlation was also found between cystatin C and creatinine resp. CrCl in patients (r = 0,66 /-0,71), but not in healthy subjects (r = 0,21/- 0,01). This fact could be explained by higher sensitivity of cystatine for renal function and its independence of the nutritional status of the organism (muscles mass, protein intake). We have calculated an equation for the conversion of  serum value of cystatin C to CrCl (CrCl=33,4x1/cystatin C+21,1), from which we can assess a degree of renal function impairment.</p>
      </sec>
   </bdy>
</art>
